Prediction of tyrosine sulfation sites in animal viruses

Biochemical and Biophysical Research Communications

Volumn 312, Issue 4, 2003, Pages 1154-1158

  Lin, Henry C ^a   Tsai, Kevin ^a   Chang, Brian L ^a   Liu, Justin ^a   Young, Melinda ^a   Hsu, Willy ^a   Louie, Samuel ^b   Nicholas Jr , Hugh B ^c   Rosenquist, Grace L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PITTSBURGH SUPERCOMPUTING CENTER   (United States)

Author keywords

Cytomegalovirus; Influenza A; Post translational modification; Rotavirus; Sulfation; Tyrosine; Virus

Indexed keywords

HEMAGGLUTININ; LIGAND; TYROSINE SULFATE; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CYTOMEGALOVIRUS; DATA BASE; HOST CELL; IMMUNE RESPONSE; INFLUENZA VIRUS A; NONHUMAN; POLYOMA VIRUS; POSITRON; POSITRON SPECIFIC SCORING MATRIX; PRIORITY JOURNAL; PROTEIN INTERACTION; RECOGNITION; ROTAVIRUS; SCORING SYSTEM; SULFATION; TRANSLATION INITIATION; VARICELLA ZOSTER VIRUS; VIRUS ADSORPTION; VIRUS INFECTION;

ANIMALIA; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 3; POLYOMAVIRUS; ROTAVIRUS;

EID: 0344064128     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.047     Document Type: Article

References (27)

1. Moore K.L. The biology and enzymology of protein tyrosine O-sulfation. J. Biol. Chem. 278:2003;24243-24246.
2. Huttner W.B. Sulphation of tyrosine residues - a widespread modification of proteins. Nature. 299:1982;273-276.
3. Nicholas H.B. Jr., Chan S.S., Rosenquist G.L. Reevaluation of the determinants of tyrosine sulfation. Endocrine. 11:1999;285-292.
4. Huttner W.B. Tyrosine sulfation and the secretory pathway. Annu. Rev. Physiol. 50:1988;363-376.
5. Bernimoulin M.P., Zeng X.L., Abbal C., Giraud S., Martinez M., Michielin O., Schapira M., Spertini O. Molecular basis of leukocyte rolling on PSGL-1. Predominant role of core-2 O-glycans and of tyrosine sulfate residue 51. J. Biol. Chem. 278:2003;37-47.
6. Gao J., Choe H., Bota D., Wright P.L., Gerard C., Gerard N.P. Sulfation of tyrosine 174 in the human C3aR is essential for binding of C3a Anaphylatoxin3t. J. Biol. Chem. 278:2003;37902-37908.
7. Kehoe J.W., Bertozzi C.R. Tyrosine sulfation: a modulator of extracellular protein-protein interactions. Chem. Biol. 7:2000;R57-R61.
8. Farzan M., Mirzabekov T., Kolchinsky P., Wyatt R., Cayabyab M., Gerard N.P., Gerard C., Sodroski J., Choe H. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell. 96:1999;667-676.
9. Choe H., Li W., Wright P.L., Vasilieva N., Venturi M., Huang C.C., Grundner C., Dorfman T., Zwick M.B., Wang L., Rosenberg E.S., Kwong P.D., Burton D.R., Robinson J.E., Sodroski J.G., Farzan M. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell. 114:2003;161-170.
10. Ludlow J.W., Consigli R.A. Polyomavirus major capsid protein VP1 is modified by tyrosine sulfuration. J. Virol. 61:1987;1708-1711.
11. Edson C.M. Tyrosine sulfation of varicella-zoster virus envelope glycoprotein gpl. Virology. 197:1993;159-165.
12. Metz C.E. Basic principles of ROC analysis. Semin. Nucl. Med. 8:1978;283-298.
13. Baigent S.J., McCauley J.W. Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission. Bioessays. 25:2003;657-671.
14. Webster R.G. The importance of animal influenza for human disease. Vaccine. 20:2002;S16-S20.
15. Weis W., Brown J.H., Cusack S., Paulson J.C., Skehel J.J., Wiley D.C. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature. 333:1988;426-431.
16. Sauter N.K., Hanson J.E., Glick G.D., Brown J.H., Crowther R.L., Park S.J., Skehel J.J., Wiley D.C. Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry. 31:1992;9609-9621.
17. Graham K.L., Halasz P., Tan Y., Hewish M.J., Takada Y., Mackow E.R., Robinson M.K., Coulson B.S. Integrin-using rotaviruses bind. α2β1 integrin α2 I domain via VP4 DGE site and recognize αX β2 and αV β3 by using VP7 during cell entry J. Virol. 77:2003;9969-9978.
18. Enouf V., Chwetzoff S., Trugnan G., Cohen J. Interactions of rotavirus VP4 spike protein with the endosomal protein Rab5 and the prenylated Rab acceptor PRA1. J. Virol. 77:2003;7041-7047.
19. Mota-Hernandez F., Calva J.J., Gutierrez-Camacho C., Villa-Contreras S., Arias C.F., Padilla-Noriega L., Guiscafre-Gallardo H., de Lourdes Guerrero M., Lopez S., Munoz O., Contreras J.F., Cedillo R., Herrera I., Puerto F.I. Rotavirus diarrhea severity is related to the VP4 type in Mexican children. J. Clin. Microbiol. 41:2003;3158-3162.
20. Bissinger A.L., Sinzger C., Kaiserling E., Jahn G. Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J. Med. Virol. 67:2002;200-206.
21. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., Power C.A. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52:2000;145-176.
22. Doranz B.J., Orsini M.J., Turner J.D., Hoffman T.L., Berson J.F., Hoxie J.A., Peiper S.C., Brass L.F., Doms R.W. Identification of CXCR4 domains that support co-receptor and chemokine receptor functions. J. Virol. 73:1999;2752-2761.
23. Monteclaro F.S., Charo I.F. The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. J. Biol. Chem. 271:1996;19084-19092.
24. Blanpain C., Doranz B.J., Vakili J., Rucker J., Govaerts C., Baik S.S., Lorthioir O., Migeotte I., Libert F., Baleux F., Vassart G., Doms R.W., Parmentier M. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein. J. Biol. Chem. 274:1999;34719-34727.
25. Mizoue L.S., Bazan J.F., Johnson E.C., Handel T.M. Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1. Biochemistry. 38:1999;1402-1414.
26. Bodaghi B., Jones T.R., Zipeto D., Vita C., Sun L., Laurent L., Arenzana-Seisdedos F., Virelizier J.L., Michelson S. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J. Exp. Med. 188:1998;855-866.
27. Vieira J., Schall T.J., Corey L., Geballe A.P. Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J. Virol. 72:1998;8158-8165.